Cart
sales@molnova.com
IRAK-4 protein kinase inhibitor 2
CAS No. 301675-24-1
IRAK-4 protein kinase inhibitor 2( —— )
Catalog No. M28816 CAS No. 301675-24-1
IRAK-4 protein kinase inhibitor 2 is a potent interleukin-1 receptor-associated kinase-4 (IRAK-4) inhibitor(IC50 = 4 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 35 | Get Quote |
|
| 25MG | 56 | Get Quote |
|
| 50MG | 82 | Get Quote |
|
| 100MG | 120 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIRAK-4 protein kinase inhibitor 2
-
NoteResearch use only, not for human use.
-
Brief DescriptionIRAK-4 protein kinase inhibitor 2 is a potent interleukin-1 receptor-associated kinase-4 (IRAK-4) inhibitor(IC50 = 4 μM).
-
DescriptionIRAK-4 protein kinase inhibitor 2 is a potent interleukin-1 receptor-associated kinase-4 (IRAK-4) inhibitor(IC50 = 4 μM).(In Vitro):IRAK-4 protein kinase inhibitor 2 inhibited IRAK-1 (IC50 <10 μM) as well.
-
In VitroIRAK-4 protein kinase inhibitor 2 (compound 1) also inhibits IRAK-1, with an IC50 of <10 μM.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIRAK
-
Recptorα1-adrenoceptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number301675-24-1
-
Formula Weight282.259
-
Molecular FormulaC14H10N4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 10 mg/mL (35.43 mM)
-
SMILES[O-][N+](=O)c1cccc(c1)C(=O)Nc1nc2ccccc2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Boschi D, et al. New potential uroselective NO-donor alpha1-antagonists. J Med Chem. 2003 Aug 14;46(17):3762-5.
molnova catalog
related products
-
IRAK inhibitor 1
IRAK inhibitor 1 is a potent IRAK-4 inhibitor with IC50 of 216 nM.
-
IRAK4-IN-8
IRAK4-IN-8 (VI-177) is an IRAK4 inhibitor used to study diseases related to cancer and inflammation.
-
IRAK4-IN-20
IRAK4-IN-20 is a potent and orally active IRAK4 inhibitor (IC50:3.55 nM). IRAK4-IN-20, which has anti-inflammatory, antitumor and anticancer effects, is often used to treat acute respiratory distress syndrome (ARDS).
